Packaging and storage
Preserve in well-closed, light-resistant containers, in a cool place.
Identification
The retention time of the major peak in the chromatogram of the
Assay preparation corresponds to that in the chromatogram of the
Standard preparation as obtained in the
Assay.
Dissolution 711
Medium:
water; 500 mL.
Apparatus 2:
50 rpm.
Time:
15 minutes.
Procedure
Place 1 Capsule in each vessel, and allow the Capsule to sink to the bottom of the vessel before starting rotation of the blade. Observe the Capsules, and record the time taken for each capsule shell to rupture.
Tolerances
The requirements are met if all of the Capsules tested rupture in not more than 15 minutes. If 1 or 2 of the Capsules rupture in more than 15 but not more than 30 minutes, repeat the test on 12 additional Capsules. Not more than 2 of the total of 18 Capsules tested rupture in more than 15 but not more than 30 minutes.
Assay
Mobile phase, Resolution solution, Standard preparation, and Chromatographic system
Proceed as directed in the
Assay under
Dronabinol.
Assay preparation
Weigh and mix the contents of not less than 20 Capsules. Transfer an accurately weighed portion of the capsule contents, equivalent to about 20 mg of dronabinol, to a 100-mL volumetric flask, dilute with dehydrated alcohol to volume, and mix.
Procedure
Proceed as directed for
Procedure in the
Assay under
Dronabinol. Calculate the quantity, in mg, of dronabinol (C
21H
30O
2) in the portion of Capsules taken by the formula:
100C(rU / rS),
in which
C is the concentration, in mg per mL, of USP
D9-Tetrahydrocannabinol RS in the
Standard preparation, and
rU and
rS are the dronabinol peak responses obtained from the
Assay preparation and the
Standard preparation, respectively.